Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G Feb 2, 2024 SC 13G
SC 13G Feb 2, 2024 SC 13G
SC 13D Jan 31, 2024
4 Jan 26, 2024 4
4 Jan 26, 2024 4
4 Jan 26, 2024 4
4 Jan 26, 2024 4
4 Jan 26, 2024 4
4 Jan 24, 2024 4
4 Jan 24, 2024 4
4 Jan 24, 2024 4
SC 13D/A Jan 24, 2024 SC 13D/A
8-K Jan 22, 2024 8-K
8-K Jan 8, 2024 8-K
UPLOAD Dec 28, 2023
S-1/A Dec 21, 2023 S-1/A
8-K Dec 21, 2023 8-K
UPLOAD Nov 15, 2023
SC 13G Nov 13, 2023
10-Q Nov 9, 2023 10-Q
8-K Nov 9, 2023 8-K
8-K Oct 25, 2023 8-K
S-8 Oct 4, 2023 S-8
S-3 Oct 4, 2023 S-3
4 Oct 3, 2023 OWNERSHIP DOCUMENT
← Newer Page 10 of 27 · 660 filings Older →